Empower CBD Clinics Visits Climb By 478% In Q1 As Coronavirus Stress Drives Demand For CBD

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB)  has a database that almost every medical cannabis and CBD company would  kill for.  Patient visits increased 800% in February. 590% in March and  480% for Q1.  But will Coronavirus social gathering imitations put the  clinic network at risk?

No.  In fact, it has had the opposite  effect, with the clinics being designated an essential service.   Moreover, Empower has had to actually increase operating hours due to  demand from existing patients who need their CBD medication more than  ever, as well as, new patients who are experiencing anxiety and stress  through the COVID-19 pandemic.

Moreover, the Company has also  entered expanded into telemedicine  across multiple states for patients who can't get to a clinic but need a  consultation with doctors over the phone to determine the best CBD  medications for home delivery.

Watch this interview with the Company's CEO, Steven McAuley, who is  Six Sigma certified under the quality initiative of legendary GE  chairman Jack Welch. We've never seen a Six Sigma certified CEO in the  Canadian small cap markets. Never .... which also explains how McAuley  has been able to guide Empower Clinics through the most disruptive  retail environment in recent history.

Grab your favourite beverage and settle in to watch what may be your next great small cap investment